Pharma News

RM-191A by RR MedSciences for Neuropathic Pain (Neuralgia): Likelihood of Approval

RM-191A is under clinical development by RR MedSciences and currently in Phase II for Neuropathic Pain (Neuralgia).

Source link
#RM191A #MedSciences #Neuropathic #Pain #Neuralgia #Likelihood #Approval

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *